<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05072509</url>
  </required_header>
  <id_info>
    <org_study_id>2021-598</org_study_id>
    <nct_id>NCT05072509</nct_id>
  </id_info>
  <brief_title>Assessment of the Endovascular Aortic Aneurysm Repair's (EVAR) Main Body Lateral Movement Impact on the Rate of Reintervention After AAA's Treatment</brief_title>
  <acronym>COLONEA</acronym>
  <official_title>Endoprothesis Long-term Behavior After Subrenal Abdominal Aortic Aneurysm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association Le Don du Souffle</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The strength of movement which are applied on the EVAR are not only cranio-caudal but also&#xD;
      lateral. The movement of the EVAR's body within the aneurysm could be an instability's&#xD;
      criteria of the EVAR. The investigators would like to show that this lateral movement is a&#xD;
      risk factor of reintervention they should follow and suggest a reinforced medical follow-up&#xD;
      to avoid complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reintervention rate</measure>
    <time_frame>through study completion, an average of 5 years</time_frame>
    <description>For the the reintervention rate, all the intervention relative to a failure of the EVAR will be taken in account: as - Endoleak - Thrombosis - Conversion to open surgery - Infection - Secondary rupture</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lateral movement of the EVAR</measure>
    <time_frame>through study completion, an average of 5 years</time_frame>
    <description>The lateral movement is defined by a movement of more than 5 mm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EVAR's movements: other than lateral.</measure>
    <time_frame>1 month post-op, 6 months, 12 months, 2 years, 3 years, 4 years, 5 years.</time_frame>
    <description>Other than lateral</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Moving</measure>
    <time_frame>1 month post-op, 6 months, 12 months, 2 years, 3 years, 4 years, 5 years.</time_frame>
    <description>EVAR's movement in relation to distal or proximal anchorage zones</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance</measure>
    <time_frame>1 month post-op, 6 months, 12 months, 2 years, 3 years, 4 years, 5 years.</time_frame>
    <description>The number of CT scanner compared to the number recommended by the Haute Autorité de Santé (HAS)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients treated in the vascular surgery department of Besançon for an abdominal aortic&#xD;
        aneurysm with an endoprothesis (symptomatic or asymptomatic)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female &gt; 18 years old&#xD;
&#xD;
          -  All patients treated in the vascular surgery department of Besançon for an abdominal&#xD;
             aortic aneurysm with an endoprothesis (symptomatic or asymptomatic)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient in emergency situation (ruptured abdominal aortic aneurysm)&#xD;
&#xD;
          -  Life expectancy supposed to be inferior to 1 year&#xD;
&#xD;
          -  Legal incapacity or limited capacity&#xD;
&#xD;
          -  Pregnant female&#xD;
&#xD;
          -  Patient unlikely to cooperate with the study&#xD;
&#xD;
          -  Patient without health insurance&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Vascular Surgery Department</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Soumia SEBAIHI</last_name>
      <phone>0381218157</phone>
      <phone_ext>+33</phone_ext>
      <email>ssebaihi@chu-besancon.fr</email>
    </contact>
    <investigator>
      <last_name>Lucie SALOMON DU MONT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 16, 2021</study_first_submitted>
  <study_first_submitted_qc>October 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2021</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aortic</keyword>
  <keyword>endovascular</keyword>
  <keyword>aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

